| D |
2026-06-15 16:09 |
2026-06-12 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+5,034 |
52.6K |
+11% |
$0 |
| D |
2026-06-15 16:09 |
2026-06-12 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$69.50 |
-2,715 |
49.9K |
-5% |
-$188.7K |
| DM |
2026-02-24 |
2026-02-20+ |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+12.3K |
51.4K |
+32% |
$0 |
| DM |
2026-02-24 |
2026-02-20+ |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$70.79 |
-6,658 |
44.4K |
-13% |
-$471.3K |
| DM |
2026-02-17 |
2026-02-16 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+16.8K |
39.0K |
+76% |
$0 |
| DM |
2026-02-17 |
2026-02-16 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$79.44 |
-9,068 |
41.9K |
-18% |
-$720.4K |
| D |
2026-01-06 |
2026-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$70.31 |
-4,243 |
34.2K |
-11% |
-$298.3K |
| D |
2026-01-06 |
2026-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+7,611 |
38.4K |
+25% |
$0 |
| D |
2025-06-13 |
2025-06-12 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$54.54 |
-2,711 |
30.8K |
-8% |
-$147.9K |
| D |
2025-06-13 |
2025-06-12 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+5,035 |
33.5K |
+18% |
$0 |
| D |
2025-02-24 |
2025-02-23 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+7,012 |
32.3K |
+28% |
$0 |
| D |
2025-02-24 |
2025-02-23 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$57.75 |
-3,775 |
28.5K |
-12% |
-$218.0K |
| DM |
2025-02-18 |
2025-02-16 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+22.2K |
27.8K |
+394% |
$0 |
| DM |
2025-02-18 |
2025-02-16 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$58.29 |
-12.0K |
23.0K |
-34% |
-$696.9K |
| D |
2025-01-06 |
2025-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
M - OptEx |
$0.00 |
+7,611 |
19.3K |
+65% |
$0 |
| D |
2025-01-06 |
2025-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, CLO |
F - Tax |
$47.74 |
-4,289 |
15.0K |
-22% |
-$204.8K |
| D |
2024-02-20 |
2024-02-16 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, GC |
M - OptEx |
$0.00 |
+4,796 |
14.3K |
+51% |
$0 |
| D |
2024-02-20 |
2024-02-16 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, GC |
F - Tax |
$36.10 |
-2,577 |
11.7K |
-18% |
-$93.0K |
| D |
2024-01-05 |
2024-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, GC |
M - OptEx |
$0.00 |
+7,611 |
12.4K |
+158% |
$0 |
| D |
2024-01-05 |
2024-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, GC |
F - Tax |
$35.78 |
-2,957 |
9,461 |
-24% |
-$105.8K |
| D |
2023-01-04 |
2023-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, GC |
M - OptEx |
$0.00 |
+7,611 |
7,611 |
New |
$0 |
| D |
2023-01-04 |
2023-01-03 |
HALO |
HALOZYME THERAPEUTICS, INC. |
Snyder Mark Howard |
SVP, GC |
F - Tax |
$55.13 |
-2,804 |
4,807 |
-37% |
-$154.6K |